## Abstract The antitumor activity of highly purified tumor necrosis factor (TNF) was tested against eight kinds of murine tumor and five kinds of human tumor heterotransplanted into nude mice. Mice were treated by intravenous or intratumoral injection of TNF, commencing when the tumors were well e
Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice
โ Scribed by Katsuyuki Haranaka; Nobuko Satomi; Akiko Sakurai
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- French
- Weight
- 575 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Lovastatin, a drug commonly used in the treatment of hypercholesterolemia, has previously been reported to exert potentiated antitumor activity when combined with either tumor necrosis factor-โฃ (TNF-โฃ), cisplatin or doxorubicin in a melanoma model in mice. Since lovastatin interferes with the functi
Eight muteins of recombinant human tumor necrosis factor-a (rhTNF; 'SSSRTP \*
## Background: Resistance to apoptosis may be responsible for a principal mechanism by which cancer cells overcome anticancer therapies. among antiapoptotic signals, the transcription factor, nf-kappab, plays a pivotal role in the resistance because it is frequently activated in many primary carcin
Organotypically cultured, confronting pairs of 8 16816 cell clusters and fragments of embryonic chick or mouse heart, as used for the study of invasion in vitro, were treated with murine TNF plus IFN-gamma for 4 and 7 days. This treatment selectively killed the 816816 cells and left the heart tissue
A pharmacodynamic analysis of cis-diamminedichloroplatinum(I1) (DDP) was conducted using two human gastric cancer xenografts, SC-1-NU and MKN-45, and one human breast cancer xenograft, MX-1, grown serially in BALB/c nu/nu mice. DDP was administered intrapentoneally (ip) at a total dose of 5, 10, or